10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 328 filers reported holding 10X GENOMICS INC in Q3 2021. The put-call ratio across all filers is 2.03 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,434,305 | +126.9% | 204,468 | +207.1% | 0.02% | +100.0% |
| Q2 2023 | $3,717,827 | +84.1% | 66,580 | +83.9% | 0.01% | +175.0% |
| Q1 2023 | $2,019,598 | +313.4% | 36,200 | +170.0% | 0.00% | +100.0% |
| Q4 2022 | $488,478 | -37.1% | 13,405 | +31.4% | 0.00% | -33.3% |
| Q1 2022 | $776,000 | -44.1% | 10,200 | +43.8% | 0.00% | -40.0% |
| Q2 2021 | $1,389,000 | +168.7% | 7,094 | +148.5% | 0.01% | +150.0% |
| Q1 2021 | $517,000 | -60.7% | 2,855 | -69.3% | 0.00% | -66.7% |
| Q4 2020 | $1,317,000 | +2.1% | 9,301 | -10.1% | 0.01% | -14.3% |
| Q3 2020 | $1,290,000 | – | 10,345 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |